Abvc Biopharma (ABVC) Receivables - Affiliates (2020 - 2022)
Abvc Biopharma's (ABVC) quarterly Receivables - Affiliates came in at $3.7 million in Q2 2022, up 422.81% YoY from $710257.0 in Q2 2021, and up 36.75% on a QoQ basis from $2.7 million in Q1 2022.
Abvc Biopharma (ABVC) Receivables - Affiliates (2020 - 2022) Analysis & Trends
Abvc Biopharma (ABVC) has 3 years of Receivables - Affiliates data on file, last reported at $3.7 million in Q2 2022.
- Quarterly Receivables - Affiliates rose 422.81% year-over-year to $3.7 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $3.7 million (up 422.81% YoY) and the FY2021 annual result came in at $1.3 million, up 84.79% from the prior year.
- Receivables - Affiliates improved to $3.7 million in Q2 2022, from $2.7 million in the prior quarter.
- In the past five years, Receivables - Affiliates ranged from a high of $3.7 million in Q2 2022 to a low of $561085.0 in Q3 2021.
- A 3-year average of $1.5 million and a median of $710257.0 in 2021 frame the typical range for Receivables - Affiliates.
- Annual changes were most pronounced in 2021 — Receivables - Affiliates jumped 84.79% — and 2022, when it soared 422.81%.
- Tracing ABVC's Receivables - Affiliates over 3 years: stood at $696255.0 in 2020, then soared by 84.79% to $1.3 million in 2021, then jumped by 188.61% to $3.7 million in 2022.
- The last three Receivables - Affiliates figures came in at $3.7 million (Q2 2022), $2.7 million (Q1 2022), and $1.3 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.71 Mn |
| Jun 30, 2022 | 3.71 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 561,085.00 |
| Sep 30, 2021 | 561,085.00 |
| Jun 30, 2021 | 710,257.00 |
| Jun 30, 2021 | 710,257.00 |
| Mar 31, 2021 | 702,889.00 |
| Mar 31, 2021 | 702,889.00 |
| Dec 31, 2020 | 696,255.00 |
| Dec 31, 2020 | 696,255.00 |